Obesity PreventionHealthyW8NCT07011368
Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 Project
A study testing Intervention Group in people with Obesity Prevention and Obesity and Overweight, run by Fundació d'investigació Sanitària de les Illes Balears at 13 sites in 8 countries.
Trial summary
The goal of the HealthyW8 study (an intervention study) is: To assess the usefulness and effects of a digital-based healthy lifestyle recommender system (HRLS) on the prevention of obesity in the following propulations: schoolchildren (5-10 y) and their parents, young adults (18-25 y) and elders (>65 y). Read more about this study
- Who is it for?
- Ages 7 years and olderHealthy volunteers can take part
- Conditions the study is for
- Obesity Prevention, Obesity and Overweight, Obesity and Obesity-related Medical Conditions
- What is being tested?
- Intervention Group
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 2,720 participants
- Where
- 13 sitesin 8 countries
- Study dates
- 1 Jul 2025to 30 Jun 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 7 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Overweight (BMI between 25-30 kg/m^2)
- To have a smart phone
Who cannot join
- Individuals with manifest chronic diseases
- Individuals with cognitive diseases
- Individuas not able to lead an independent life
Trial locations and contacts
13 sites in 8 countries. Contact the study team or a site near you to ask about taking part.
13 sites in 8 countries
Spain3 sites
Centre de Recerca En Economia I Desenvolupament Agroalimentari-Upc-Irta
Castelldefels, 08860
Fundacio Institut D'Investigacio Sanitaria Illes Balears (Idisba)
Palma de Mallorca, Balearic Islands, 07122
Centro de Investigacion Y Tecnologia Agroalimentaria de Aragon
Zaragoza, 50059
Bulgaria2 sites
Virtech Ood
Sofia, 1784
Regional Cluster North-East
Varna, 9002
Germany2 sites
Leibniz-Institut Fur Praventionsforschung Und Epidemiologie - Bips Gmbh
Bremen, 28359
Deutsches Forschungszentrum Fur Kunstliche Intelligenz Gmbh
Kaiserslautern, 67663
Portugal2 sites
Universidade de Coimbra
Coimbra, 3004-531
Universidade de Evora
Evora, 7000 803
About this study
Official title: Empowering Healthy Lifestyle Behaviour Through Personalized Intervention Portfolios to Prevent and Control Obesity During Vulnerable Stages of Life: The HealthyW8 Project.
The goal of the HealthyW8 study (an intervention study) is:
To assess the usefulness and effects of a digital-based healthy lifestyle recommender system (HRLS) on the prevention of obesity in the following propulations: schoolchildren (5-10 y) and their parents, young adults (18-25 y) and elders (>65 y).
Read more
The main questions it aims to answer are:
Outcome 1: To select and validate a tool-assisted 3-mo intervention (mostly digital) by iteratively testing the HLRS on reducing risk of overweight/obesity among the described age groups.
Outcome 2: To assess the effect of 1-y interventions (mostly digital) with the HLRS described and further iteratively improved previously (outcome 1) on reducing risk of overweight/obesity at described ages.
Researchers will compare the intervention group before the intervention (baseline) and after it (3-mo intervention trial), or control group (standard care) vs. Intervention group (1-y intervention) to see changes on changes in overweight/obesity, and related parameters (body composition and biomarkers).
Participants will follow the HLRS recommendations (meal plans, physical activity and sleep pattern measures and recommendations, assessment of behavioural/psychological aspects, and motivational features through digital devices), which will be assessed by means of measurement of body weight, body composition, and biomarkers.
Read the detailed description
HealthyW8 will enhance early screening and prevention of obesity by making the scientific and technological breakthroughs necessary to support evidence-based clinical, environmental and policy-level decisions, while also directly empowering citizens to adopt healthy and sustainable lifestyle behaviours in a "push-pull" approach.
HealthyW8 will step up primary obesity prevention efforts across Europe, endowing them with a multi-disciplinary portfolio approach, i.e. a set of selective multi-component interventions that combine a large set of interventions and implementation options, focussing on diet, physical activity (PA), and psycho-emotional aspects.
The current approach considers obesity as a multifactorial phenomenon, necessitating a holistic, systemic approach accounting for the complexity of individual, interpersonal, organisational, community and public policy levels, as mutually reinforcing and supportive systems.
The attention will be focused on pivotal situations of transitions in the life-trajectory of individuals, which pose an elevated risk to progress from healthy weight to overweight and obesity, i.e. windows of opportunity to reduce the risk of developing obesity where the impact will have most leverage.
HealthyW8 targets vulnerable populations where transitional changes of lifestyle appear to be dominant: primary schoolchildren (5-12y, with active parent involvement), young adults (18-25y), and the elderly (>65y).
A central pillar of the current multiportfolio approach and intervention strategy will be a healthy lifestyle recommender solution (HLRS). Despite many apps on the market today that propose changes in dietary behaviour/PA, overweight and obesity are still on the rise across Europe. They failed to engage citizens with low interest in healthy lifestyle patterns and suffer from prominent limitations that HealthyW8 will address by developing the HLRS as a core element of our adapted intervention strategy and appropriate intervention tools.
Interventions' acceptability and feasibility to key stakeholders will be ensured by a participatory design approach, allowing stakeholders to influence from the outset their design \& development and integrate the needs of the target groups. The obesity prevention potential of interventions and/or their implementation strategies will be evaluated in over a dozen multicentre pilots (<3 months) and long-term (12 months) randomised control trials (RCTs). In parallel, it will collect user feedback on feasibility, acceptability and needs, allowing researchers to respond in real-time to problems/deviations and to capture context-related factors of success/failure.
Applying SMART criteria, HealthyW8 will achieve the following objectives:
- Expand understanding of the biological causes underlying obesogenic trends \& interactions with crosscutting environmental, behavioural \& policy factors to propose evidence-based effective obesity prevention strategies.
- Develop user-centred portfolio interventions to enhance the impact on lifestyle changes in an efficient, synergistic, long-lasting \& sustainable way.
- Iteratively optimise the intervention strategies involving vulnerable populations/those undergoing transitions to maximise impact.
- Leverage findings to EU stakeholders \& foster the multilevel uptake of solutions \& strategies.
Accordingly, multi-disciplinary portfolios of interventions adaptable to the targeted populations, and further to the individual (anthropometry, general health aspects, inflammation, oxidative stress, epigenetics, omics, microbiota, dietary \& general consulting, healthy lifestyle recommender solutions - HLRS, Human Digital Twin - HDT, policies recommendations, Open Stakeholder Pltform - OSP) will be developed. The focus on primary prevention, specifically the progression from healthy weight to overweight/obese, will allow targeting a broader population with a better cost/benefit ratio than secondary/tertiary preventions, though anticipating that the current portfolio approach and HLRS are adaptable to treatment scenarios also.
After an inventory of best practises \& relevant levers for overweight/obesity prevention \& management existing literature evidence will be synthesised. A system map for obesity prevention for the different targeted vulnerable groups and for the HDT. Via scoping, systematic and (umbrella-) reviews/meta-analyses, main drivers of the obesogenic environment will be highlighted.
These findings will be integrated in a multi-actor participatory design approach (Design Thinking, DT) into the development of the HLRS and of the HDT.
Implementation of pilot trials (<3 month; n=30 for each age group: primary schoolchildren (5-12y, with active parent involvement), young adults (18-25y), and the elderly (>65y) will be applied to validate the selected tool-assisted interventions by testing the HLRS and other health intervention strategies \& tools. Outcomes will lead to iterative tool development and a roadmap for larger long-term intervention studies.
Long term RCTs (12 months) with the same population groups will be conducted (n=55 per age group), compared vs. controls (n=55 per age group; receiving standard recommendations).
Populations will be replicated several times, participants longitudinally followed, and outcomes collected including: a) eating patterns (FFQs); b) markers related to obesity and comorbidities; c) lifestyle and cognitive aspects, psycho-emotional well-being (Emotional Guidance Scale encompassing e.g. joy, appreciation, freedom, empowerment, despair, fear); d) technological acceptance and usability (Mobile Application Rating Scale). Hence, we will apply a biopsychosocial understanding of obesity, integrating physiological, psychosocial, and contextual factors into one coherent model. Many markers/measures will be identical between countries/populations (core-endpoints), some different due to local/population-required adaptations.
Main outcome will be to assess the effect of 1 y interventions with the HLRS described and further iteratively improved in Pilot studies on reducing risk of overweight/obesity at various life-stages. Secondary objectives will be to assess the effect of interventions on body composition and metabolic and other parameters.
- Conditions
- Obesity Prevention, Obesity and Overweight, Obesity and Obesity-related Medical Conditions, Digital Health, Behavioural Science Interventions to Improve Health Equity
- Being tested
- Intervention Group
- Keywords
- Healthy lifestyle recommender system, digital empowerment, health literacy, personalised prevention, pre-obesity biomarkers, mHealth, Human Digital Twin, behavior change techniques, physical activity
- Medical subject headings
- Obesity, Overweight, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intervention GroupBehavioural
Healthy Lifestyle Recommender Solution (HLRS) will be developed as intervention tool for the trials. It integrates tools (mostly digital): a meal recommender to propose balanced and individually adapted meal plans, physical activity and sleep pattern measures and recommendations, assessment of behavioural/psychological aspects, and motivational features for sustained engagement and adherence.
Within our multi-disciplinary portfolio approach, a set of predominantly eHealth solutions applied during the intervention trials for overweight/obesity prevention, developed in a participatory design approach with relevant stakeholders. This will include the HLRS, thus combining motivational features (nudging, gamification), targeted psychological support, dietary and physical activity advice, though also additional recommendations (healthy eating guidelines...) or education materials will be provided.
Intervention trials/studies.
| Study group | Role | What they receive |
|---|---|---|
| School-children (including families) | Experimental | HLRS intervention on 5-12 year-old school-children (including families) adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages). Receives: Behavioral: Intervention Group |
| Young adults | Experimental | HLRS intervention on 18-25-year-old young adults adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages). Receives: Behavioral: Intervention Group |
| Elderly people | Experimental | HLRS intervention on >65-year-old elderly people adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages). Receives: Behavioral: Intervention Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in BMI
The Primary Outcome (to be measured every 3 months) will be the change of BMI (kg/m^2) measuring body weight in kilograms and height in meters^2 as combined to obtain BMI data (kg/m^2) after the 12-month intervention of healthy lifestyle recommender solutions (HLRS) in the selected age groups (5-12 y.o. children and families; 18-25 y.o. young adults; and >65 y.o. elderly people).
Measured: Baseline and every 3 months up to 12 months
Secondary outcomes (2)
Change of visceral body fat
The Secondary Outcome (to be measured every 3 months) will be the change of visceral body fat measuring body fat in kilograms and in percentage of body weight after the 12-month intervention of healthy lifestyle recommender solutions (HLRS) in the selected age groups (5-12 y.o. children and families; 18-25 y.o. young adults; and >65 y.o. elderly people).
Measured: Baseline and every 3 months up to 12 months
Body composition and biomarkers
Other Secondary outcomes will be several biological markers measured every 6 months:
- lipidic profile (cholesterol, LDL-c, HDL-C, triglycerides): mg/dL
- glycidic profile (fasting blood glucose, HbA1C, insulin): mg/dL
- inflammatory biomarkers (CRP, IL-1b/6/8, TNFa)
- oxidative stress biomarkers (F2-isoprostanes, malondialdehyde): ng/mL
- nutrition related markers: vitamin E, total carotenoids, total phenolics, sodium in urine: ng/dL
- gut microbiome analyses (16S rRNA): assessment of bacterial species
Measured: Baseline and every 6 months up to 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jun 2025
- Study start1 Jul 2025 (estimated)
- Primary completion15 Jul 2025 (estimated)
- Study completion30 Jun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Obesity PreventionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Intervention: 1. Pilot studies: Main objective is to validate the selected tool-assisted interventions by iteratively testing the HLRS and other health intervention tools among different end-user groups within different contexts (e.g. cultural, economic, social, physical). Pilot trials (\<3 months; n=30 per each age group: children, young adults, and elders) will assess their efficacy considering psychological/emotional states, adherence to dietary suggestions, technology acceptance, efficacy of nudges/gamification, user-friendliness of the tools, and actual usage and engagement. Outcomes will provide feedback for HLRS, including input for the HDT, and a roadmap for long-term intervention studies. 2. Long-trials: Main objective is to assess the effect of 1-y interventions with the HLRS described and further iteratively improved in Pilot trial on reducing risk of overweight/obesity at described life-stages n=55 per control \& intervention group, and described ages).
- Masking
- None (open label)
- Enrolment
- 2,720 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fundació d'investigació Sanitària de les Illes Balears
- Sponsor type
- Other government
- Collaborators
- Luxembourg Institute of Health, University of Évora, University of Coimbra, Eindhoven University of Technology, Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, Deutsches Forschungszentrum für Künstliche Intelligenz (DFKI), Technical University of Denmark
- Responsible party
- Sponsor
- Investigators
- Torsten Bohn, PhD, Principal investigator, Luxembourg Institute of Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07011368
- Sponsor's protocol ID
- HealthyW8-Pilot-and-Long-Trial
- Other IDs
- 101080645
- Acronym
- HealthyW8
- Status last verified
- Apr 2025
- First submitted
- 7 Apr 2025
- Last updated
- 1 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There are restrictions on the availability of data for this trial, due to the signed consent agreements around data sharing, which only allow access to external re-searchers for studies following the project purposes. Researchers wishing to access the trial data used in this study can make a request to pep.tur@uib.es
Publications
Vahid F, Dessenne C, Tur JA, Bouzas C, Devaux Y, Malisoux L, Monserrat-Mesquida M, Sureda A, Desai MS, Turner JD, Lamy E, Perez-Jimenez M, Ravn-Haren G, Andersen R, Forberger S, Nagrani R, Ouzzahra Y, Fontefrancesco MF, Onorati MG, Bonetti GG, de-Magistris T, Bohn T. Multicomponent (bio)markers for obesity risk prediction: a scoping review protocol. BMJ Open. 2024 Mar 8;14(3):e083558. doi: 10.1136/bmjopen-2023-083558.
PubMed 38458803Vahid F, Loyola-Leyva A, Bouzas C, Tur JA, Ivanova Y, Doychinov B, Nikolov R, Chikalanov A, De Magistris T, Halimi J, Forberger S, Stahl C, Evers S, Devaux Y, Malisoux L, Mendon P, Celebic A, Vaillant M, Gantenbein M, Skhiri L, Kallas Z, Garcia L, Bohn T; HealthyW8 consortium. Empowering healthy lifestyle behaviour through personalised intervention portfolios using a healthy lifestyle recommender system to prevent and control obesity in older adults: pilot study protocols from the HealthyW8 project. BMJ Open. 2026 Mar 25;16(3):e108771. doi: 10.1136/bmjopen-2025-108771.
PubMed 41881526
Study at a glance
From the registry record, last updated by the sponsor on 1 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Empowering Healthy Lifestyle Behaviour Through Personalized Intervention Portfolios to Prevent and Control Obesity During Vulnerable Stages of Life: The HealthyW8 Project.
- ClinicalTrials.gov ID
- NCT07011368
- Acronym / sponsor ID
- HealthyW8 / HealthyW8-Pilot-and-Long-Trial
- Conditions
- Obesity Prevention, Obesity and Overweight, Obesity and Obesity-related Medical Conditions, Digital Health, Behavioural Science Interventions to Improve Health Equity
- Keywords
- Healthy lifestyle recommender system, digital empowerment, health literacy, personalised prevention, pre-obesity biomarkers, mHealth, Human Digital Twin, behavior change techniques
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 2,720 participants (estimated)
- Lead sponsor
- Fundació d'investigació Sanitària de les Illes BalearsOther government
- Collaborators
- Luxembourg Institute of Health, University of Évora, University of Coimbra, Eindhoven University of Technology, Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, Deutsches Forschungszentrum für Künstliche Intelligenz (DFKI), Technical University of Denmark
- Study start
- 1 Jul 2025 (estimated)
- Primary completion
- 15 Jul 2025 (estimated)
- Study completion
- 30 Jun 2028 (estimated)
- First posted
- 8 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of the HealthyW8 study (an intervention study) is:
To assess the usefulness and effects of a digital-based healthy lifestyle recommender system (HRLS) on the prevention of obesity in the following propulations: schoolchildren (5-10 y) and their parents, young adults (18-25 y) and elders (>65 y).
The main questions it aims to answer are:
Outcome 1: To select and validate a tool-assisted 3-mo intervention (mostly digital) by iteratively testing the HLRS on reducing risk of overweight/obesity among the described age groups.
Outcome 2: To assess the effect of 1-y interventions (mostly digital) with the HLRS described and further iteratively improved previously (outcome 1) on reducing risk of overweight/obesity at described ages.
Researchers will compare the intervention group before the intervention (baseline) and after it (3-mo intervention trial), or control group (standard care) vs. Intervention group (1-y intervention) to see changes on changes in overweight/obesity, and related parameters (body composition and biomarkers).
Participants will follow the HLRS recommendations (meal plans, physical activity and sleep pattern measures and recommendations, assessment of behavioural/psychological aspects, and motivational features through digital devices), which will be assessed by means of measurement of body weight, body composition, and biomarkers.
Detailed description
HealthyW8 will enhance early screening and prevention of obesity by making the scientific and technological breakthroughs necessary to support evidence-based clinical, environmental and policy-level decisions, while also directly empowering citizens to adopt healthy and sustainable lifestyle behaviours in a "push-pull" approach.
HealthyW8 will step up primary obesity prevention efforts across Europe, endowing them with a multi-disciplinary portfolio approach, i.e. a set of selective multi-component interventions that combine a large set of interventions and implementation options, focussing on diet, physical activity (PA), and psycho-emotional aspects.
The current approach considers obesity as a multifactorial phenomenon, necessitating a holistic, systemic approach accounting for the complexity of individual, interpersonal, organisational, community and public policy levels, as mutually reinforcing and supportive systems.
The attention will be focused on pivotal situations of transitions in the life-trajectory of individuals, which pose an elevated risk to progress from healthy weight to overweight and obesity, i.e. windows of opportunity to reduce the risk of developing obesity where the impact will have most leverage.
HealthyW8 targets vulnerable populations where transitional changes of lifestyle appear to be dominant: primary schoolchildren (5-12y, with active parent involvement), young adults (18-25y), and the elderly (>65y).
A central pillar of the current multiportfolio approach and intervention strategy will be a healthy lifestyle recommender solution (HLRS). Despite many apps on the market today that propose changes in dietary behaviour/PA, overweight and obesity are still on the rise across Europe. They failed to engage citizens with low interest in healthy lifestyle patterns and suffer from prominent limitations that HealthyW8 will address by developing the HLRS as a core element of our adapted intervention strategy and appropriate intervention tools.
Interventions' acceptability and feasibility to key stakeholders will be ensured by a participatory design approach, allowing stakeholders to influence from the outset their design \& development and integrate the needs of the target groups. The obesity prevention potential of interventions and/or their implementation strategies will be evaluated in over a dozen multicentre pilots (<3 months) and long-term (12 months) randomised control trials (RCTs). In parallel, it will collect user feedback on feasibility, acceptability and needs, allowing researchers to respond in real-time to problems/deviations and to capture context-related factors of success/failure.
Applying SMART criteria, HealthyW8 will achieve the following objectives:
- Expand understanding of the biological causes underlying obesogenic trends \& interactions with crosscutting environmental, behavioural \& policy factors to propose evidence-based effective obesity prevention strategies.
- Develop user-centred portfolio interventions to enhance the impact on lifestyle changes in an efficient, synergistic, long-lasting \& sustainable way.
- Iteratively optimise the intervention strategies involving vulnerable populations/those undergoing transitions to maximise impact.
- Leverage findings to EU stakeholders \& foster the multilevel uptake of solutions \& strategies.
Accordingly, multi-disciplinary portfolios of interventions adaptable to the targeted populations, and further to the individual (anthropometry, general health aspects, inflammation, oxidative stress, epigenetics, omics, microbiota, dietary \& general consulting, healthy lifestyle recommender solutions - HLRS, Human Digital Twin - HDT, policies recommendations, Open Stakeholder Pltform - OSP) will be developed. The focus on primary prevention, specifically the progression from healthy weight to overweight/obese, will allow targeting a broader population with a better cost/benefit ratio than secondary/tertiary preventions, though anticipating that the current portfolio approach and HLRS are adaptable to treatment scenarios also.
After an inventory of best practises \& relevant levers for overweight/obesity prevention \& management existing literature evidence will be synthesised. A system map for obesity prevention for the different targeted vulnerable groups and for the HDT. Via scoping, systematic and (umbrella-) reviews/meta-analyses, main drivers of the obesogenic environment will be highlighted.
These findings will be integrated in a multi-actor participatory design approach (Design Thinking, DT) into the development of the HLRS and of the HDT.
Implementation of pilot trials (<3 month; n=30 for each age group: primary schoolchildren (5-12y, with active parent involvement), young adults (18-25y), and the elderly (>65y) will be applied to validate the selected tool-assisted interventions by testing the HLRS and other health intervention strategies \& tools. Outcomes will lead to iterative tool development and a roadmap for larger long-term intervention studies.
Long term RCTs (12 months) with the same population groups will be conducted (n=55 per age group), compared vs. controls (n=55 per age group; receiving standard recommendations).
Populations will be replicated several times, participants longitudinally followed, and outcomes collected including: a) eating patterns (FFQs); b) markers related to obesity and comorbidities; c) lifestyle and cognitive aspects, psycho-emotional well-being (Emotional Guidance Scale encompassing e.g. joy, appreciation, freedom, empowerment, despair, fear); d) technological acceptance and usability (Mobile Application Rating Scale). Hence, we will apply a biopsychosocial understanding of obesity, integrating physiological, psychosocial, and contextual factors into one coherent model. Many markers/measures will be identical between countries/populations (core-endpoints), some different due to local/population-required adaptations.
Main outcome will be to assess the effect of 1 y interventions with the HLRS described and further iteratively improved in Pilot studies on reducing risk of overweight/obesity at various life-stages. Secondary objectives will be to assess the effect of interventions on body composition and metabolic and other parameters.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
- Model description
- Intervention: 1. Pilot studies: Main objective is to validate the selected tool-assisted interventions by iteratively testing the HLRS and other health intervention tools among different end-user groups within different contexts (e.g. cultural, economic, social, physical). Pilot trials (<3 months; n=30 per each age group: children, young adults, and elders) will assess their efficacy considering psychological/emotional states, adherence to dietary suggestions, technology acceptance, efficacy of nudges/gamification, user-friendliness of the tools, and actual usage and engagement. Outcomes will provide feedback for HLRS, including input for the HDT, and a roadmap for long-term intervention studies. 2. Long-trials: Main objective is to assess the effect of 1-y interventions with the HLRS described and further iteratively improved in Pilot trial on reducing risk of overweight/obesity at described life-stages n=55 per control \& intervention group, and described ages).
| Arm | Type | Receives |
|---|---|---|
| School-children (including families) | Experimental | Behavioral: Intervention GroupHLRS intervention on 5-12 year-old school-children (including families) adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages). |
| Young adults | Experimental | Behavioral: Intervention GroupHLRS intervention on 18-25-year-old young adults adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages). |
| Elderly people | Experimental | Behavioral: Intervention GroupHLRS intervention on >65-year-old elderly people adapted to the countries in which they will be deployed (e.g.: adaptation to cultural food habits, translation into national languages). |
Who may qualify
- Ages
- 7 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- Overweight (BMI between 25-30 kg/m^2)
- To have a smart phone
Key exclusion criteria (3 listed)
- Individuals with manifest chronic diseases
- Individuals with cognitive diseases
- Individuas not able to lead an independent life
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intervention GroupHealthy Lifestyle Recommender Solution (HLRS) will be developed as intervention tool for the trials. It integrates tools (mostly digital): a meal recommender to propose balanced and individually adapted meal plans, physical activity and sleep pattern measures and recommendations, assessment of behavioural/psychological aspects, and motivational features for sustained engagement and adherence. Within our multi-disciplinary portfolio approach, a set of predominantly eHealth solutions applied during the intervention trials for overweight/obesity prevention, developed in a participatory design approach with relevant stakeholders. This will include the HLRS, thus combining motivational features (nudging, gamification), targeted psychological support, dietary and physical activity advice, though also additional recommendations (healthy eating guidelines...) or education materials will be provided. Intervention trials/studies. | Behavioural | Elderly people, School-children (including families), Young adults |
Primary outcome
Change in BMI
Time frame: Baseline and every 3 months up to 12 months
The Primary Outcome (to be measured every 3 months) will be the change of BMI (kg/m^2) measuring body weight in kilograms and height in meters^2 as combined to obtain BMI data (kg/m^2) after the 12-month intervention of healthy lifestyle recommender solutions (HLRS) in the selected age groups (5-12 y.o. children and families; 18-25 y.o. young adults; and >65 y.o. elderly people).
2 secondary outcomes
Change of visceral body fat
Time frame: Baseline and every 3 months up to 12 months
Body composition and biomarkers
Time frame: Baseline and every 6 months up to 12 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jul 2025.
- Results publication: PubMed 38458803Vahid F, Dessenne C, Tur JA, Bouzas C, Devaux Y, Malisoux L, Monserrat-Mesquida M, Sureda A, Desai MS, Turner JD, Lamy E, Perez-Jimenez M, Ravn-Haren G, Andersen R, Forberger S, Nagrani R, Ouzzahra Y, Fontefrancesco MF, Onorati MG, Bonetti GG, de-Magistris T, Bohn T. Multicomponent (bio)markers for obesity risk prediction: a scoping review protocol. BMJ Open. 2024 Mar 8;14(3):e083558. doi: 10.1136/bmjopen-2023-083558.
- Derived from this study: PubMed 41881526Vahid F, Loyola-Leyva A, Bouzas C, Tur JA, Ivanova Y, Doychinov B, Nikolov R, Chikalanov A, De Magistris T, Halimi J, Forberger S, Stahl C, Evers S, Devaux Y, Malisoux L, Mendon P, Celebic A, Vaillant M, Gantenbein M, Skhiri L, Kallas Z, Garcia L, Bohn T; HealthyW8 consortium. Empowering healthy lifestyle behaviour through personalised intervention portfolios using a healthy lifestyle recommender system to prevent and control obesity in older adults: pilot study protocols from the HealthyW8 project. BMJ Open. 2026 Mar 25;16(3):e108771. doi: 10.1136/bmjopen-2025-108771.
- HealthyW8: Empowering Healthy Lifestyle BehaviourLink provided by the sponsor.
- Individual participant dataSharing planned: No. There are restrictions on the availability of data for this trial, due to the signed consent agreements around data sharing, which only allow access to external re-searchers for studies following the project purposes. Researchers wishing to access the trial data used in this study can make a request to pep.tur@uib.es
Related trials for Obesity Prevention
Not yet recruitingObservational study
Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
Abdominal Aortic Aneurysm, Morbid Obesity
RecruitingPhase 3
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Overweight, Prediabetic State
Recruiting
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
Joint Osteoarthritis, Atherosclerosis of the Distal Arteries, Without Gangrene
Recruiting
National Childhood Obesity Prevention Programme BE FIT 24
Childhood Obesity
RecruitingPhase 3
Weight Gain Prevention in Adolescents and Young Adults
Healthy Volunteers
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Torsten Bohn, PhD principal investigator
Luxembourg Institute of Health
13 sites in 8 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Intervention Group in people with Obesity Prevention and Obesity and Overweight, run by Fundació d'investigació Sanitària de les Illes Balears at 13 sites in 8 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 1 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 13 sites in Spain, Bulgaria, Germany, Portugal, Denmark and 3 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Josep A Tur, PhD (+34971173146, pep.tur@uib.es), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in BMI (time frame: Baseline and every 3 months up to 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07011368, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2025.